Stevanato Group S.p.A.NYSE: STVN

Stevanato Group to Participate in Upcoming Investor Conferences

· Issued by Stevanato Group S.p.A. via Business Wire

Summary by 6ix AI

Stevanato Group S.p.A., which provides drug containment, drug delivery and diagnostic products to the pharmaceutical, biotechnology and life sciences industries, will take part in three investor conferences, starting with the Jefferies Global Healthcare Conference in London from November 16 to November 19, 2026.

Key details

  • At the Jefferies conference, the company will give a presentation on Wednesday, November 18, at 3:00 p.m. (GMT), with a live webcast on its website under the Investors section and a replay available for approximately 90 days.
  • The company will also host meetings at the Wolfe Research Virtual Small and Mid-Cap Conference on Wednesday, December 2, 2026.
  • It will also host meetings at the Citi 2026 Global Healthcare Conference on Wednesday, December 2, 2026, in Miami, Florida.

6ix AI wrote this summary from the release below and checked it against the release.

PIOMBINO DESE, Italy--(BUSINESS WIRE)--Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology, and life sciences industries, announced today that it will participate in three upcoming investor conferences.

The Company will participate in the Jefferies Global Healthcare Conference taking place from Monday, November 16, 2026, to Thursday, November 19, 2026, in London. The Company will host a presentation on Wednesday, November 18, at 3:00 p.m. (GMT). A live webcast will be available on the Company’s website at www.stevanatogroup.com under the "Investors" section. A replay of the webcast will be available for approximately 90 days after the event.

The Company will also host meetings at the Wolfe Research Virtual Small and Mid-Cap Conference on Wednesday, December 2, 2026, and the Citi 2026 Global Healthcare Conference taking place on Wednesday, December 2, 2026, in Miami, Florida.

About Stevanato Group

Founded in 1949, Stevanato Group is a leading global provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology, and life sciences industries. The Group delivers an integrated, end-to-end portfolio of products, processes and services that address customer needs across the entire drug life cycle at each of the development, clinical and commercial stages. Stevanato Group’s core capabilities in scientific research and development, its commitment to technical innovation and its engineering excellence are central to its ability to offer value-added solutions to clients.

For more information, please visit: www.stevanatogroup.com.

View original source (Business Wire)Stevanato Group S.p.A. on 6ix

Story so far

Earlier from Stevanato

All Stevanato news releases